T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRMW
2201
DELISTED
Primo Water Corporation
PRMW
| $426K | ﹤0.01% |
27,400
+2,170
| +9% | +$31.5K |
|
2202
OneSpan
OSPN
$624M
| $422K | ﹤0.01% |
37,684
-20,940
| -36% | -$241K |
|
2203
iHeartMedia
IHRT
$464M
| $421K | ﹤0.01% |
68,599
+1,741
| +3% | +$13.4K |
|
|
INN
2204
Summit Hotel Properties
INN
$656M
| $421K | ﹤0.01% |
58,340
+5,691
| +11% | +$44.6K |
|
2205
TriMas Corp
TRS
$1.39B
| $420K | ﹤0.01% |
15,138
+616
| +4% | +$16.5K |
|
|
SLCA
2206
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $419K | ﹤0.01% |
33,496
+1,508
| +5% | +$19.3K |
|
2207
Genesco
GCO
$394M
| $418K | ﹤0.01% |
9,093
+212
| +2% | +$9.62K |
|
|
TRUE
2208
DELISTED
TrueCar
TRUE
| $417K | ﹤0.01% |
166,077
-24,356
| -13% | -$50.7K |
|
2209
The Greenbrier Companies
GBX
$1.42B
| $415K | ﹤0.01% |
12,363
+468
| +4% | +$15.6K |
|
2210
Mercury Insurance
MCY
$5.81B
| $415K | ﹤0.01% |
12,132
-1,778
| -13% | -$59.1K |
|
2211
Theravance Biopharma
TBPH
$878M
| $415K | ﹤0.01% |
36,968
-43,609
| -54% | -$458K |
|
2212
Asure Software
ASUR
$251M
| $414K | ﹤0.01% |
44,280
+100
| +0.2% | +$713 |
|
2213
Comstock Resources
CRK
$3.99B
| $414K | ﹤0.01% |
30,214
+1,272
| +4% | +$21.7K |
|
2214
Rhythm Pharmaceuticals
RYTM
$7.99B
| $414K | ﹤0.01% |
14,200
-2,100
| -13% | -$54K |
|
2215
Titan Machinery
TITN
$420M
| $414K | ﹤0.01% |
10,415
+382
| +4% | +$13.6K |
|
2216
Health Catalyst
HCAT
$132M
| $412K | ﹤0.01% |
38,787
+3,613
| +10% | +$34.9K |
|
|
RFP
2217
DELISTED
Resolute Forest Products Inc.
RFP
| $411K | ﹤0.01% |
19,038
-3,222
| -14% | -$67.4K |
|
|
CHCT
2218
Community Healthcare Trust
CHCT
$433M
| $410K | ﹤0.01% |
11,448
+359
| +3% | +$12.2K |
|
2219
Zumiez
ZUMZ
$319M
| $410K | ﹤0.01% |
18,857
+155
| +0.8% | +$3.44K |
|
2220
Accuray
ARAY
$32.9M
| $408K | ﹤0.01% |
194,994
| – | – |
|
|
PLL
2221
DELISTED
Piedmont Lithium
PLL
| $408K | ﹤0.01% |
9,261
+339
| +4% | +$18.8K |
|
|
PTRA
2222
DELISTED
Proterra Inc. Common Stock
PTRA
| $408K | ﹤0.01% |
108,132
-5,549
| -5% | -$29.3K |
|
2223
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $407K | ﹤0.01% |
4,302
| – | – |
|
2224
RE/MAX Holdings
RMAX
$265M
| $407K | ﹤0.01% |
21,813
+3,870
| +22% | +$73.8K |
|
2225
Unitil
UTL
$992M
| $407K | ﹤0.01% |
7,930
-1,595
| -17% | -$81.2K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.